Captrust Financial Advisors Poly Pid Ltd. Transaction History

Captrust Financial Advisors

  • $33 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022
SELL
$4.35 - $5.76 $434 - $576
-100 Reduced 4.87%
1,953 $9,000
Q2 2021

Aug 16, 2021
BUY
$8.4 - $9.99 $16,405 - $19,510
1,953 Added 1953.0%
2,053 $19,000
Q3 2020

Nov 17, 2020
BUY
$11.0 - $17.33 $1,100 - $1,732
100 New
100 $1,000

About PolyPid Ltd.

PYPD Quotes by TradingView
  • Ticker PYPD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,551,200
  • Market Cap $69.6M
  • Description
  • PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...
More about PYPD
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email